Nathaniel B Langer
Overview
Explore the profile of Nathaniel B Langer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Villavicencio M, Li S, Leifer A, Gustafson J, Osho A, Wolfe S, et al.
JTCVS Open
. 2023 Jul;
14:602-614.
PMID: 37425441
Objective: The study objective was to assess the safety and efficacy of a preemptive direct-acting antiviral therapy in lung transplants from hepatitis C virus donors to uninfected recipients. Methods: This...
12.
van Kampen A, Goudot G, Butte S, Paneitz D, Borger M, Badhwar V, et al.
Front Cardiovasc Med
. 2023 Apr;
10:1113908.
PMID: 37025683
Background: Patients with mitral valve prolapse (MVP) requiring surgical repair (MVr) are increasingly operated using minimally invasive strategies. Skill acquisition may be facilitated by a dedicated MVr program. We present...
13.
Khan K, Khan O, Chen C, Liu Y, Kandanelly R, Jamiel P, et al.
J Am Coll Cardiol
. 2023 Mar;
81(13):1235-1244.
PMID: 36990542
Background: Afterload from moderate aortic stenosis (AS) may contribute to adverse outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Objectives: The authors evaluated clinical outcomes in patients...
14.
Shagabayeva L, Osho A, Moonsamy P, Mohan N, Li S, Wolfe S, et al.
Clin Transplant
. 2022 Jul;
36(11):e14782.
PMID: 35848518
Objectives: We provide a contemporary consideration of long-term outcomes and trends of induction therapy use following lung transplantation in the United States. Methods: We reviewed the United Network for Organ...
15.
16.
Flannery L, Etiwy M, Camacho A, Liu R, Patel N, Tavil-Shatelyan A, et al.
J Am Heart Assoc
. 2022 May;
11(11):e025065.
PMID: 35621198
Background Many patients with severe aortic stenosis (AS) and an indication for aortic valve replacement (AVR) do not undergo treatment. The reasons for this have not been well studied in...
17.
Li S, Patel N, Flannery L, Selberg A, Kandanelly R, Morrison F, et al.
J Am Coll Cardiol
. 2022 Mar;
79(9):864-877.
PMID: 35241220
Background: Despite the rapid growth of aortic valve replacement (AVR) for aortic stenosis (AS), limited data suggest symptomatic severe AS remains undertreated. Objectives: This study sought to investigate temporal trends...
18.
Osho A, Moonsamy P, Ethridge B, Leya G, DAlessandro D, Jassar A, et al.
Ann Surg
. 2020 Sep;
276(1):200-204.
PMID: 32889881
Objective: This manuscript describes the rationale and design of a randomized, controlled trial comparing outcomes with Warfarin vs Novel Oral Anticoagulant (NOAC) therapy in patients with new onset atrial fibrillation...
19.
Langer N, Vlahakes G
J Thorac Cardiovasc Surg
. 2020 Mar;
162(2):626-627.
PMID: 32173101
No abstract available.
20.
Langer N, Vlahakes G
J Thorac Cardiovasc Surg
. 2019 Oct;
160(6):1488-1489.
PMID: 31653421
No abstract available.